THYMOGEN 20MG

Thymogen 20mg is a synthetic dipeptide bioregulator with the sequence Glu-Trp (Glutamyl-Tryptophan), isolated from Thymalin — the thymus-derived polypeptide complex developed by Professors Vladimir Khavinson and Vyacheslav Morozov at the Saint Petersburg Institute of Bioregulation and Gerontology. As the purified synthetic analog of the active immunomodulatory fraction of Thymalin, Thymogen represents one of the most studied thymic bioregulators in the Khavinson peptide family, with a research history spanning over four decades and published in peer-reviewed international journals including ScienceDirect.

Research into Thymogen focuses on its tissue-specific regulatory activity on immune cells, particularly T-lymphocyte populations and thymic function. Studies have examined its proposed mechanism of binding to the AACG DNA sequence in lymphocyte nuclei, modulation of cAMP and cGMP balance in spleen lymphocytes, and its effects on thymic involution — the progressive age-related atrophy of the thymus that drives immunosenescence in aging organisms. Preclinical and human studies from Russian clinical populations have examined Thymogen for reduced infection rates, improved T-cell counts, and mortality reduction in elderly subjects.

Beyond Health Lab supplies Thymogen 20mg as a research-grade lyophilized compound, HPLC-verified for 99% purity, shipped within 24 hours from Mexico.

For research use only. Not intended for human or animal consumption.

FAQ:

What is Thymogen and how does it differ from Thymalin or Thymosin Alpha-1?
Thymogen (Glu-Trp) is the purified synthetic dipeptide isolated from Thymalin, the complex thymic polypeptide extract. While Thymalin contains a mixture of short peptides targeting overall thymic function, Thymogen is the smallest active fraction — making it more defined and reproducible for controlled research designs. Thymosin Alpha-1 operates primarily on mature T-cells post-thymic processing, while Thymogen is studied for its effects upstream — at the level of thymic gene regulation and T-lymphocyte differentiation, making it a distinct and complementary research tool.

What immune mechanisms has Thymogen been studied for in preclinical research?
Published research has examined Thymogen for its binding to the AACG nucleotide sequence in lymphocyte DNA, modulation of cAMP/cGMP balance in spleen lymphocytes, regulation of T-cell differentiation markers, and its effects on immune responses in models of secondary immune deficiency and fungal infection. Key published references include Morozov and Khavinson (ScienceDirect, 1998) and Demidov et al. on cAMP/cGMP phosphodiesterase activity in spleen lymphocytes.

What is thymic involution and why is Thymogen relevant to aging research?
The thymus — the master organ of adaptive immunity — begins atrophying after puberty and is largely non-functional in most people by middle age. This thymic involution drives immunosenescence: the progressive decline in T-cell production that leaves aging organisms more vulnerable to infections and immune dysregulation. Thymogen is studied as a tool for investigating whether thymic bioregulator peptides can restore aspects of thymic gene expression and T-cell output in aged preclinical models.

How should Thymogen 20mg be stored?
Store lyophilized Thymogen at 2–8°C away from light and moisture. Once reconstituted with bacteriostatic water, keep refrigerated and use within 28 days for optimal stability and research-grade performance.